Skip to main content

Table 2 Biochemical measurements of US data and Chinese populations

From: Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?

 US data (n = 11,844)Chinese data (n = 51,229)P value
(NHANES vs Chinese)
Total (n = 11,844)non-NAFLD Group (n = 7571)NAFLD Group (n = 4273)P valueTotal (n = 51,229)non-NAFLD Group (n = 37,334)NAFLD Group (n = 13,895)P value
Serum cholesterol (mmol/l)5.29 ± 1.185.21 ± 1.155.42 ± 1.22< 0.0014.71 ± 0.944.58 ± 0.905.04 ± 0.98< 0.001< 0.001
Serum triglyceride (mmol/l)1.65 ± 1.281.56 ± 1.212.00 ± 1.46< 0.0011.57 ± 1.421.26 ± 1.022.39 ± 1.92< 0.001< 0.001
Uric acid (umol/l)313.86 ± 87.36306.04 ± 82.63342.51 ± 97.66< 0.001307.37 ± 92.74287.9 ± 86.75359.69 ± 87.96< 0.001< 0.001
NFS−2.09 ± 1.63−2.36 ± 1.50−1.10 ± 1.71< 0.001−1.76 ± 1.24−1.83 ± 1.22−1.55 ± 1.25< 0.001< 0.001
FIB40.93 ± 0.650.82 ± 0.561.30 ± 0.81< 0.0011.32 ± 0.851.31 ± 0.881.33 ± 0.750.010< 0.001
APRI0.21 ± 0.190.21 ± 0.190.22 ± 0.200.0020.34 ± 0.260.31 ± 0.260.38 ± 0.24< 0.001< 0.001